The effectiveness of remote methods of cognitive behavioral therapy for chronic insomnia and the possibilities of combined interventions

Golovatyuk A.O.; Poluektov M.G.

doi:https://doi.org/10.17116/jnevro202312305258

Golovatyuk A.O.

Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0001-6304-3479

Poluektov M.G.

Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0001-6215-0918

The effectiveness of remote methods of cognitive behavioral therapy for chronic insomnia and the possibilities of combined interventions

Authors:

Golovatyuk A.O., Poluektov M.G.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(5‑2): 58‑62

DOI: 10.17116/jnevro202312305258

Read: 2037 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Golovatyuk AO, Poluektov MG. The effectiveness of remote methods of cognitive behavioral therapy for chronic insomnia and the possibilities of combined interventions. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(5‑2):58‑62. (In Russ.)
https://doi.org/10.17116/jnevro202312305258

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Consensus of the Russian Society of Sleep Medicine on the real-world application of cognitive-behavioral therapy of insomnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):38-45

Sleep disturbance in patients with chronic nonspecific neck pain before and after radiofrequency denervation. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):87-91

Results of combined treatment of patients with cerebral gliomas. P.A. Herzen Journal of Oncology. 2024;(6):18-22

Prognostic factors and preoperative therapy in resectable intrahepatic cholangiocarcinoma. Pirogov Russian Journal of Surgery. 2025;(1):5-13

Neoadjuvant drug therapy and oncological outcomes in patients with stage I–II breast cancer. P.A. Herzen Journal of Oncology. 2025;(1):5-12

Surgical treatment of nasal liquorea in patients with posttraumatic defect of posterior wall of the frontal sinus. Russian Rhinology. 2025;(1):65-71

A personalized approach to the choice of treatment options for rectal cancer patients taking into account the risk of progression. P.A. Herzen Journal of Oncology. 2025;(4):14-21

Sleep disorders after COVID-19 in patients with primary headaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):127-132

Abstract:

Chronic insomnia is one of the most common sleep disorders in the world. The representation of chronic insomnia in the general population reaches 10—20% according to various sources. The most effective method of treating chronic insomnia with a sustained effect is cognitive behavioral therapy of insomnia (CBT-I). Among the disadvantages of CBT-I is its low availability (due to the lack of specialists) and high cost. Methods of delivered CBT-I are becoming increasingly relevant. The advantage of such type of CBT-I is the possibility of its use by a wide group of people. There are different ways of conducting delivered CBT, including those that do not require the direct participation of a specialist. The effectiveness of this method of treatment is comparable to full-time CBT-I.

Keywords:

chronic insomnia

CBT-I

online CBT-I

combined treatment

Authors:

Golovatyuk A.O.

Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0001-6304-3479

Poluektov M.G.

Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0001-6215-0918

Received:

04.04.2023

Accepted:

05.04.2023

Close metadata

References:

American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.
Morin C, Jarrin D. Epidemiology of Insomnia: Prevalence, Course, Risk Factors, and Public Health Burden. Sleep Med Clin. 2022;17(2):173-191. https://doi.org/10.1016/j.jsmc.2022.03.003
Ohayon M, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res. 2003;37(1):9-15. https://doi.org/10.1016/s0022-3956(02)00052-3
Martin S, Aikens J, Chervin R. Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia. Sleep Med Rev. 2004;8(1):63-72. https://doi.org/10.1016/j.smrv.2003.08.001
Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675-700. https://doi.org/10.1111/jsr.12594
Singh J, Badr M, Diebert W, et al. American Academy of Sleep Medicine (AASM) Position Paper for the Use of Telemedicine for the Diagnosis and Treatment of Sleep Disorders. J Clin Sleep Med. 2015;11(10):1187-1198. https://doi.org/10.5664/jcsm.5098
Yu J, Kuhn E, Miller K, Taylor K. Smartphone apps for insomnia: examining existing apps’ usability and adherence to evidence-based principles for insomnia management. Transl Behav Med. 2019;9(1):110-119. https://doi.org/10.1093/tbm/iby014
Thompson W, Quay T, Rojas-Fernandez C, et al. Atypical antipsychotics for insomnia: a systematic review. Sleep Med. 2016;22:13-17. https://doi.org/10.1016/j.sleep.2016.04.003
Van Gastel A. Drug-Induced Insomnia and Excessive Sleepiness. Sleep Med Clin. 2018;13(2):147-159. https://doi.org/10.1016/j.jsmc.2018.02.001
Krystal A. A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice. Sleep Med Rev. 2009;13(4):265-274. https://doi.org/10.1016/j.smrv.2008.08.001
Buysse D. Insomnia. JAMA. 2013;309(7):706-716. https://doi.org/10.1001/jama.2013.193
Stahl S. Stahl’s Essential Psychopharmacology, Neuroscientific Basis and Practical Applications, Applications, 3rd ed. Cambridge University Press, NY; 2008.
Nutt D, Stahl S. Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol. 2010;24(11):1601-1612. https://doi.org/10.1177/0269881109106927
Olsen R, Sieghart W. GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology. 2009;56(1):141-148. https://doi.org/10.1016/j.neuropharm.2008.07.045
Randall S, Roehrs T, Roth T. Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study. Sleep. 2012;35:1551-1557. https://doi.org/10.5665/sleep.2208
Krystal A, Erman M, Zammit G, et al.; ZOLONG Study Group. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep. 2008;31(1):79-90. https://doi.org/10.1093/sleep/31.1.79
Trauer J, Qian M, Doyle J, et al. Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Ann Intern Med. 2015;163(3):191-204. https://doi.org/10.7326/M14-2841
Harvey A, Bélanger L, Talbot L, et al. Comparative efficacy of behavior therapy, cognitive therapy, and cognitive behavior therapy for chronic insomnia: a randomized controlled trial. J Consult Clin Psychol. 2014;82(4):670-683. https://doi.org/10.1037/a0036606
van Straten A, van der Zweerde T, Kleiboer A, et al. Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Med Rev. 2018;38:3-16. https://doi.org/10.1016/j.smrv.2017.02.001
Koffel E, Vitiello M, McCurry S, et al. Predictors of Adherence to Psychological Treatment for Insomnia and Pain: Analysis from a Randomized Trial. Clin J Pain. 2018;34(4):375-382. https://doi.org/10.1097/AJP.0000000000000546
Morin C, Vallières A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009;301(19):2005-2015. https://doi.org/10.1001/jama.2009.682
Morin C, Beaulieu-Bonneau S, Ivers H, et al. Speed and trajectory of changes of insomnia symptoms during acute treatment with cognitive-behavioral therapy, singly and combined with medication. Sleep Med. 2014;15(6):701-707. https://doi.org/10.1016/j.sleep.2014.02.004
Beaulieu-Bonneau S, Ivers H, Guay B, Morin C. Long-Term Maintenance of Therapeutic Gains Associated With Cognitive-Behavioral Therapy for Insomnia Delivered Alone or Combined With Zolpidem. Sleep. 2017;40(3):zsx002. https://doi.org/10.1093/sleep/zsx002
Arnedt J, Cuddihy L, Swanson L, et al. Randomized controlled trial of telephone-delivered cognitive behavioral therapy for chronic insomnia. Sleep. 2013;36(3):353-362. https://doi.org/10.5665/sleep.2448
Ritterband L, Thorndike F, Gonder-Frederick L, et al. Efficacy of an Internet-based behavioral intervention for adults with insomnia. Arch Gen Psychiatry. 2009;66(7):692-698. https://doi.org/10.1001/archgenpsychiatry.2009.66
Espie C, Kyle S, Williams C, et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep. 2012;35(6):769-781. https://doi.org/10.5665/sleep.1872
Lancee J, van Straten A, Morina N, et al. Guided Online or Face-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled Trial. Sleep. 2016;39(1):183-191. https://doi.org/10.5665/sleep.5344
Taylor D, Peterson A, Pruiksma K, et al. Internet and In-Person Cognitive Behavioral Therapy for Insomnia in Military Personnel: A Randomized Clinical Trial. Sleep. 2017;40(6):10.1093/sleep/zsx075. https://doi.org/10.1093/sleep/zsx075
Zachariae R, Lyby M, Ritterband L, O’Toole M. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia — A systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2016;30:1-10. https://doi.org/10.1016/j.smrv.2015.10.004
Morin C. Profile of Somryst Prescription Digital Therapeutic for Chronic Insomnia: Overview of Safety and Efficacy. Expert Rev Med Devices. 2020;17(12):1239-1248. https://doi.org/10.1080/17434440.2020.1852929
https://www.rlsnet.ru/drugs/gomeostres-36811 https://www.rlsnet.ru/drugs/gomeostres-36811
Romasenko LV, Alexandrovsky YuA, Makhov VM, et al.Generalized anxiety disorder in patients of general medical practice: clinic, treatment. Psychiatry and Psychopharmacotherapy. 2015;17(3):56-59. (In Russ.).